Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - COST OF REVENUE
Cost of Revenue FATE - Fate Therapeutics, Inc.
162 M
LAST VALUE
425.74%
2 YEAR CAGR
23.61%
5 YEAR CAGR
29.70%
10 YEAR CAGR